Up 50%: Merrimack Pharmaceuticals' Groundbreaking News
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Thu May 01, 5:30PM CDT
Shares in Merrimack Pharmaceuticals (NASDAQ: MACK) gained over 50% today on great news regarding a phase 3 trial for its MM-398 drug for pancreatic cancer. In combination with 5-flouroacil and leucovorin, MM-398 generated a 1.9 month lift in...
Final Glance: Biotechnology companies
AP - Thu May 01, 5:07PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
Midday Glance: Biotechnology companies
AP - Thu May 01, 12:46PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Early Glance: Biotechnology companies
AP - Thu May 01, 10:09AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver
PR Newswire - Thu May 01, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for KO, BIDU, URBN, CELG, and TSL.
Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 30, 9:55AM CDT
Gilead's (GILD) Sovaldi remained in the limelight with sales blowing past expectations.
Earnings Roundup: Celgene's Rock-Solid Quarter Offers Opportunity
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 29, 5:30PM CDT
Celgene is one of the most prolific deal makers in the biotech industry, inking dozens of collaborations with emerging biotechs working on the next big thing in medicine. Celgene's collaborations aim to expand upon an already-impressive...
After Yesterday's Rally of 2.75% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 29, 3:45PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $142.10 to a high of $148.00. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $144.95 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Celgene Rises 2.75% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Apr 29, 3:45PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $142.10 to a high of $148.00. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $144.95 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A
at The Street - Tue Apr 29, 3:26PM CDT
Some sharp opinions expressed by healthcare deal-makers at the Allicense 2014 conference.
Could Celgene Beat the Biotech Slide?
Cory Renauer, The Motley Fool - Motley Fool - Mon Apr 28, 5:30PM CDT
Last Thursday, Celgene 's first quarter earnings call left the market with mixed emotions. Adjusted earnings per share of $1.67 beat estimates by just $0.02. Revenue grew 18.5% on year to $1.73 billion, $40 million less than the Street was...
Why Gilead Sciences (GILD) Stock Is Up Today
at The Street - Mon Apr 28, 10:16AM CDT
Shares of Gilead Sciences (GILD) are higher today after it was reported that the biopharmaceutical company had a nine day winning streak end last week but it continues to outperform other big biotech stocks like Amgen (AMGN), Celgene (CELG) and...